Patient care, life sciences

Recent Transactions

HCP advises small and middle-market healthcare companies. Its partners have completed more than 100 transactions in the healthcare sector with a value in excess of $1bn. HCP advises healthcare companies in identifying and structuring value-enhancing transactions primarily between the US and Europe. It focuses on business and assets divestures, private equity and venture capital fund raising.

Arthesys - Sale of Non-Core Assets by French IVC Company
IGNA -  Sale of France Largest Genetic Testing Laboratory
CathNet Sciences SA – Sale of a Medtech company controlled by Boston Scientific
Sebia - Secondary Buy- Out of French Diagnostics Company
Biosil - Sale of UK breast and Silicone Implant company Biosil
Nagor - Sale of UK breast and Silicone Implant company Nagor
Renal Services – Private placement of convertible loan notes
Minvasys - Sale of French Cardiovascular Devices Manufacturer
Stirling Square Capital Parnters - MBO of European Dialysis Provider
Medicom - Sale of Bang & Olufsen Drug Delivery Devices Subsidiary
OrthoRehab - Sale of US Orthopedic Products company OrthoRehab
Labnova – Sale of specialty chemical company
Lipoxen – identified and structured pre-IPO investment